Breaking News

Epygenix Therapeutics Names Darren Cline as President and CEO

Cline is a seasoned pharmaceutical industry executive with an over-30-year track record of building key commercial organizations and functions.

Author Image

By: Charlie Sternberg

Associate Editor

Epygenix Therapeutics, a clinical-stage biopharmaceutical company developing drugs for rare and intractable forms of genetic epilepsy, has appointed Darren Cline as president and chief executive officer and also director of the Board.   Cline will succeed Hahn-Jun Lee, M.Sc., Ph.D., who will continue serving on the Board of Directors and working as a transitionary advisor to the new CEO.    Cline is a seasoned pharmaceutical industry executive with an over-30-year track record of building ke...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters